Dr Shirish D Sherlekar is a trained doctor by profession. He have worked for five years at the P.D. Hinduja Hospital and Research centre as a resident surgeon and the Hospital of the Kaiga atomic power plant as a Medical director before shifting to the pharmaceutical industry in 1991.
Since joining the industry 1991 he has worked in both multinationals and large Indian Pharmaceutical companies. He started his career with Burroughs Wellcome and moved to GlaxoWellcome (now GlaxoSmithkline) after its merger. During the tenure worked in medical affairs/regulatory affairs and Product management and was exposed to clinical trials, medico-marketing activities and as a marketing person handled products like third generation cephalosporins and neuromuscular blocking agents. Moved to Pfizer in clinical research doing Phase II and Phase III trial for registration of new chemical entities in the US and Europe. In Wockhardt he headed the Pharma division responsible for all medical and regulatory affairs. Joined Reckitt Piramal a joint venture between Reckitt Benckiser and Nicholas Piramal and was responsible for all the pharmaceutical activity for the organization in the south Asia region. He then joined AstraZeneca as part of the senior management team and was responsible for the department of regulatory, corporate affairs and business development. Took the position at a crucial time when the company had changed from Astra IDL to AstraZeneca. After taking over set up the department and gave direction to the regulatory and corporate affairs function. Has been actively involved on the implementation of the TRIPS and Patent issues in India and along with many bodies have worked with the government to implement TRIPS compliant regime.
In 2006 he moved to the growing area of Knowledge process outsourcing and joined Tata Consultancy Services Ltd. At TATA Consultancy Services Ltd. he Head the Life Sciences Practice. His responsibilities include leading a team of professionals c